aap Implantate AG Announces Capital Increase to Fund Trauma Business Expansion

aap Implantate AG is conducting a capital increase, offering up to 1,486,563 new shares at EUR 1.35 each, with a subscription period from November 6 to 20, 2026. The company also plans to convert EUR 1.7 million in shareholder loans into equity. This financial maneuver aims to bolster liquidity and support the next phase of growth for its trauma business, following full MDR certification and improved Q3 2026 revenue performance.